Package 0615-8264-39

Brand: memantine hydrochloride

Generic: memantine hydrochloride
NDC Package

Package Facts

Identity

Package NDC 0615-8264-39
Digits Only 0615826439
Product NDC 0615-8264
Product ID 0615-8264_194f162d-30bc-420f-85ae-fca98d00705a
Description

30 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (0615-8264-39)

Marketing

Marketing Status
Discontinued 2026-07-31
Brand memantine hydrochloride
Generic memantine hydrochloride
Sample Package No

Linked Drug Pages (1)

memantine hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "194f162d-30bc-420f-85ae-fca98d00705a", "openfda": {"unii": ["JY0WD0UA60"], "rxcui": ["996609"], "spl_set_id": ["e2a371f6-8bfe-4049-b9ca-0ab3d726379e"], "manufacturer_name": ["NCS HealthCare of KY, LLC dba Vangard Labs"]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (0615-8264-39)", "package_ndc": "0615-8264-39", "marketing_end_date": "20260731", "marketing_start_date": "20190109"}], "brand_name": "memantine hydrochloride", "product_id": "0615-8264_194f162d-30bc-420f-85ae-fca98d00705a", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["N-methyl-D-aspartate Receptor Antagonist [EPC]", "NMDA Receptor Antagonists [MoA]"], "product_ndc": "0615-8264", "generic_name": "memantine hydrochloride", "labeler_name": "NCS HealthCare of KY, LLC dba Vangard Labs", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "memantine hydrochloride", "active_ingredients": [{"name": "MEMANTINE HYDROCHLORIDE", "strength": "28 mg/1"}], "application_number": "ANDA206028", "marketing_category": "ANDA", "marketing_end_date": "20260731", "marketing_start_date": "20180220"}